Diagnos Laboratorium Shares Owned By Insiders vs. Total Debt
| DGNS Stock | IDR 218.00 2.00 0.91% |
For Diagnos Laboratorium profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Diagnos Laboratorium to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Diagnos Laboratorium Utama utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Diagnos Laboratorium's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Diagnos Laboratorium Utama over time as well as its relative position and ranking within its peers.
Diagnos |
Diagnos Laboratorium Total Debt vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Diagnos Laboratorium's current stock value. Our valuation model uses many indicators to compare Diagnos Laboratorium value to that of its competitors to determine the firm's financial worth. Diagnos Laboratorium Utama is one of the top stocks in shares owned by insiders category among its peers. It also is rated as one of the top companies in total debt category among its peers making up about 130,632,990 of Total Debt per Shares Owned By Insiders. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diagnos Laboratorium's earnings, one of the primary drivers of an investment's value.Diagnos Total Debt vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Diagnos Laboratorium |
| = | 80.00 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Diagnos Laboratorium |
| = | 10.45 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Diagnos Total Debt vs Competition
Diagnos Laboratorium Utama is rated as one of the top companies in total debt category among its peers. Total debt of Diagnostics & Research industry is currently estimated at about 1.54 Trillion. Diagnos Laboratorium maintains roughly 10.45 Billion in total debt contributing less than 1% to equities under Diagnostics & Research industry.
Diagnos Laboratorium Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Diagnos Laboratorium, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Diagnos Laboratorium will eventually generate negative long term returns. The profitability progress is the general direction of Diagnos Laboratorium's change in net profit over the period of time. It can combine multiple indicators of Diagnos Laboratorium, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people.
Diagnos Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Diagnos Laboratorium. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Diagnos Laboratorium position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Diagnos Laboratorium's important profitability drivers and their relationship over time.
Use Diagnos Laboratorium in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diagnos Laboratorium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnos Laboratorium will appreciate offsetting losses from the drop in the long position's value.Diagnos Laboratorium Pair Trading
Diagnos Laboratorium Utama Pair Trading Analysis
The ability to find closely correlated positions to Diagnos Laboratorium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diagnos Laboratorium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diagnos Laboratorium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diagnos Laboratorium Utama to buy it.
The correlation of Diagnos Laboratorium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diagnos Laboratorium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diagnos Laboratorium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diagnos Laboratorium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Diagnos Laboratorium position
In addition to having Diagnos Laboratorium in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials Thematic Idea Now
Financials
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Diagnos Stock
To fully project Diagnos Laboratorium's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Diagnos Laboratorium at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Diagnos Laboratorium's income statement, its balance sheet, and the statement of cash flows.